MMP9 and prostate carcinoma: Odibenzo-p-dioxin (TCDD) exposure up-regulated the expression and activity of MMP9 in a variety of malignant tumors, including melanoma cells, urothelial cancer cells, prostate cancer cells, and gastric cancer cells (32).